申请人:PORTOLA PHARM INC
公开号:WO2010129802A1
公开(公告)日:2010-11-11
The present invention is directed to compounds of formula (I) and tautomers and pharmaceutically acceptable salts thereof which are selective inhibitors of JAK. The present invention is also directed to intermediates used in making such compounds, the preparation of such a compound, pharmaceutical compositions containing such a compound, methods of inhibition JAK activity, and methods to prevent or treat a number of conditions mediated at least in part by JAK activity.
本发明涉及式(I)的化合物及其互变异构体和药学上可接受的盐,这些化合物是JAK的选择性抑制剂。本发明还涉及用于制备这种化合物的中间体,制备这种化合物,含有这种化合物的药物组合物,抑制JAK活性的方法,以及预防或治疗至少部分由JAK活性介导的多种疾病的方法。